N-piperidine Ibrutinib
Modify Date: 2024-02-08 17:03:43
N-piperidine Ibrutinib structure
|
Common Name | N-piperidine Ibrutinib | ||
|---|---|---|---|---|
| CAS Number | 330785-90-5 | Molecular Weight | 386.45 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C22H22N6O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of N-piperidine IbrutinibBTK ligand 1 (compound 1) is a ligand targeting Bruton’s tyrosine kinase (Btk). BTK ligand 1 can combine with E3 ligase ligand (Ligand for E3 Ligase) through PROTAC Linker to form PROTAC. PROTACs targeting Btk can be used in the study of chronic lymphocytic leukemia (CLL) and other BK cell malignancies[1]. |
| Name | 3-(4-Phenoxyphenyl)-1-(4-piperidinyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine |
|---|
| Description | BTK ligand 1 (compound 1) is a ligand targeting Bruton’s tyrosine kinase (Btk). BTK ligand 1 can combine with E3 ligase ligand (Ligand for E3 Ligase) through PROTAC Linker to form PROTAC. PROTACs targeting Btk can be used in the study of chronic lymphocytic leukemia (CLL) and other BK cell malignancies[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C22H22N6O |
|---|---|
| Molecular Weight | 386.45 |
| Storage condition | -20℃ |